Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-1,010,0128 Monoclonal anti-TK1 antibodies
Monoclonal antibodies and fragments thereof are capable of binding to a serum form of human TK1. Kits and methods involve the use of such monoclonal antibodies...
US-1,010,0127 Passive immunization for Staphylococcus infections
Disclosed herein are monoclonal antibodies or binding portion thereof that bind specifically to a Staphylococcus spp. autolysin N-acetylmuramoyl-L-alanine...
US-1,010,0126 Antibody therapeutics that bind PSMA
There is disclosed compositions and methods relating to or derived from anti-PSMA antibodies. More specifically, there is disclosed fully human antibodies that...
US-1,010,0125 Humanised anti kallikrein-2 antibody
The present invention provides antibody polypeptides with binding specificity for human kallikrein-2 (hK2), wherein the antibody polypeptide comprises (a) a...
US-1,010,0124 Antibodies directed to HER-3 and uses thereof
The present invention relates to binding proteins that bind to HER-3 and polynucleotides encoding the same. Expression vectors and host cells comprising the...
US-1,010,0123 Anti-C10orf54 antibodies and uses thereof
The present disclosure relates generally to anti-C10orf54 antibodies, including antibody-drug conjugates comprising the antibodies, and methods of their use.
US-1,010,0121 Anti-mesothelin binding proteins
The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies and bispecific antibodies which...
US-1,010,0120 Antibody which specifically binds to human CRTH2
There is provided an anti-human CRTH2 antibody which has desired activity by recognizing and binding to a specific human CRTH2; the antibody fragment; DNA which...
US-1,010,0119 Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer
The present invention provides an antibody or an antigen-binding fragment thereof with binding specificity for human interleukin-1 receptor accessory protein...
US-1,010,0118 Antibody therapeutics that bind CD123
There is disclosed compositions and methods relating to or derived from anti-CD123 antibodies. More specifically, there is disclosed fully human antibodies that...
US-1,010,0117 Insulin-like growth factor 1 receptor-specific antibodies and uses thereof
The blood-brain barrier (BBB) prevents transport of molecules larger than 500 Dal tons from blood to brain. Receptor-mediated transcytosis (RMT) facilitates...
US-1,010,0116 Fc.gamma.RIIB-specific antibodies and methods of use thereof
The present invention relates to antibodies or fragments thereof that specifically bind Fc.gamma.RIIB, particularly human Fc.gamma.RIIB, with greater affinity...
US-1,010,0115 Methods for the treatment of vascularizing cancers
The invention concerns therapeutic compositions for the treatment of vascularizing cancers, especially, glioblastoma. In particular, the invention is directed...
US-1,010,0114 Antibodies specific for TROP-2 and their uses
The present invention provides antibodies that specifically bind to trophoblast cell-surface antigen-2 (Trop-2). The invention further provides antibody...
US-1,010,0113 Maternal TH17 cells and psychiatric disorders
Methods are presented herein for reducing the risk of developing a psychiatric disorder (e.g., autism like disorder) in a fetus involving administering an...
US-1,010,0112 Therapeutic agents for the treatment of diseases associated with undesired cell proliferation
The present invention relates to inhibitors of the expression and/or activity of LIF for the treatment of cancer. Particularly, the present invention provides...
US-1,010,0111 Stable and soluble antibodies inhibiting TNF alpha
The present invention relates to particularly stable and soluble scFv antibodies and Fab fragments specific for TNF, which comprise specific light chain and...
US-1,010,0110 Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the...
The present invention relates to biological materials against HGF and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods...
US-1,010,0109 Anti-activin A antibodies and uses thereof
The disclosure provides compositions and methods relating to or derived from anti-activin A binding proteins, including antibodies. In particular embodiments,...
US-1,010,0108 Antibodies to HGF and compositions containing
The present invention is directed to antibodies and fragments thereof having binding specificity for HGF. Another embodiment of this invention relates to the...
US-1,010,0107 Method for identifying a compound useful with myosin regulatory light chain polypeptide antibody for treatment...
Provided is a means for inhibiting a function of CD69, whereby allowing suppression of an inflammatory response. That is, provided are: a composition for...
US-1,010,0106 Single domain serum albumin binding protein
Disclosed herein are single domain serum albumins binding proteins with improved thermal stability, binding affinities, and robust aggregation profiles. Also...
US-1,010,0105 Anti-polyubiquitin antibodies and methods of use
The invention provides anti-polyubiquitin antibodies and methods of using the same.
US-1,010,0104 Methods of diagnosing tau-protein-associated disease
The present invention relates to methods and compositions for the therapeutic and diagnostic use in the treatment of diseases and disorders which are caused by...
US-1,010,0103 Opsonic and protective monoclonal antibodies against gram-positive pathogens
The present invention in the fields of immunology and infectious diseases relates to opsonic and protective antibodies that are specific for Gram-positive...
US-1,010,0102 Compositions and methods for inhibiting pathogen infection
The presently-disclosed subject matter relates to antibodies, compositions, and methods for inhibiting and treating pathogen infection and providing...
US-1,010,0101 Compositions and methods related to viral vaccines
Provided herein are methods and compositions relating to Infectious Bursal Disease Virus (IBDV), and vaccines for treatment and prevention thereof.
US-1,010,0100 Metallothionein-derived peptide fragments
The present invention relates to neural cell survival, differentiation and proliferation promoting peptide fragments derived from metallothioneins (MT),...
US-1,010,0099 Method of producing recombinant high molecular weight vWF in cell culture
Among other aspects, the present invention relates to cell culture conditions for producing high molecular weight vWF, in particular, highly multimericWF with a...
US-1,010,0098 Insulin production methods and proinsulin constructs
Novel proinsulins and glargine, aspart and Lis-Pro proinsulin analogs having specific amino acid and/or nucleic acid modifications suitable for improved methods...
US-1,010,0097 GIP-GLP-1 dual agonist compounds and methods
The present invention relates to truncated GIP analogs which comprise one or more substitutions as compared to wild-type GIP and which may have the property of...
US-1,010,0096 Tissue protective peptides and uses thereof
The present invention is directed to novel tissue protective peptides. The tissue protective peptides of the invention may bind to a tissue protective receptor...
US-1,010,0095 Resistant mutant 90 kDa heat shock protein
An object to be solved by the present invention is to identify patients resistant to known HSP90 inhibitors, and to provide a novel therapeutic agent for...
US-1,010,0094 Fusion proteins, cells, and kits for characterizing Botulinum toxin
Compositions for characterization of Botulinum toxin (BoNT) are described that include a genetically modified cell that is transfected with an artificial...
US-1,010,0093 Polypeptides and immunizing compositions containing Burkholderia polypeptides and methods of use
This disclosure provides isolated polypeptides isolatable from a Burkholderia spp., compositions that include one or more of the polypeptides, and methods for...
US-1,010,0092 Compositions and methods to detect various infectious organisms
The invention relates to compositions and methods for the detection of various infectious organisms, including heartworm (Dirofilaria immitis), Ehrlichia Canis,...
US-1,010,0091 Fusion protein for HIV-1 gp120 antigen detection
The present disclosure relates to novel fusion proteins that bind to the HIV-1 gp120 antigen. The present disclosure also relates to nucleic acids, plasmids and...
US-1,010,0090 Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
In one aspect, the invention relates to substituted urea depsipeptide analogs, derivatives thereof, and related compounds, which are useful as activators with...
US-1,010,0089 Process for the preparation of cyclic depsipeptides
Processes for preparing compounds of Formula (1) and Formula (2) are described, wherein X, Y, Z, R.sub.1-R.sub.7, L and n are defined herein. Intermediates...
US-1,010,0088 Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms
The present invention relates to a compound of the following formula (I): ##STR00001## in which at least one and only one group chosen among R.sup.5, R.sup.6...
US-1,010,0087 Immunogenic WT-1 peptides and methods of use thereof
This invention provides peptides, immunogenic compositions and vaccines, and methods of treating, reducing the incidence of, and inducing immune responses to a...
US-1,010,0086 Peptide and uses thereof
This present invention provides a novel peptide for inhibiting growth of microorganisms, a pharmaceutical composition, an antimicrobial composition comprising...
US-1,010,0085 Immunotherapy against several tumors including neuronal and brain tumors
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the...
US-1,010,0084 Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
Template-fixed .beta.-hairpin peptidomimetics of the general formulae ##STR00001## wherein Z is a chain of 11 .alpha.-amino acid residues which, depending on...
US-1,010,0083 Leukemia stem cell targeting ligands and methods of use
The present invention is directed to C-type lectin-like molecule-1 (CLL1) specific ligand peptides, comprising the amino acid motif LR(S/T), and methods of...
US-1,010,0082 Hexapeptide for neuroprotection against a .beta. toxicity
The present investigation involves designing of a novel hexapeptide, which spontaneously self-assembles to form nanovesicles in physiological conditions. This...
US-1,010,0081 Trapping reagents for reactive metabolites screening
The present invention provides compounds of Formula (I) and (II): ##STR00001## wherein R.sup.1, R.sup.2, R.sup.4, R.sup.5, R.sup.6, X and n are as defined...
US-1,010,0080 Split inteins and uses thereof
The present invention relates generally to robust split inteins. The split inteins described herein are active over a large temperature range, including...
US-1,010,0079 Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof
The present invention relates to the development of the cationic progesterone compounds as a novel anti-tumor agent. The present invention provides a method for...
US-1,010,0078 Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in...
The present invention regards nanoparticles comprising a sterol and a component derived from Quillaja saponaria Molina selected from quillaja acid and quillaja...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.